1. Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? 
Michel Bolla 
European Urology Supplements 
Volume 9, Issue 11, Pages (December 2010)
DOI: /j.eursup
Copyright © 2010 European Association of Urology Terms and Conditions

2. Fig. 1
Cumulative incidence up to 10 yr in 875 men with locally advanced prostate cancer (PCa) treated with androgen-deprivation therapy (ADT) with or without radiation therapy (RT) of (A) PCa-specific mortality and (B) overall mortality. Reproduced with permission from Widmark et al [8].
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

3. Fig. 2
Overall survival at 10 yr in patients with locally advanced prostate cancer treated with radiation therapy plus short-term androgen-deprivation therapy (ADT) or long-term ADT [9].
CI=confidence interval; STADT=short-term androgen-deprivation therapy; LTADT=long-term androgen-deprivation therapy.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

4. Fig. 3
Mean scores for specific domains of the European Organisation for Research and Treatment of Cancer QLQ-C30 scale in patients with locally advanced prostate cancer randomised to treatment with short-term androgen-deprivation therapy (ADT) or long-term ADT following radiation therapy. Reproduced with permission from Bolla et al [9].
STADT=short-term androgen-deprivation therapy; LTADT=long-term androgen-deprivation therapy; Pre-tx=pretreatment.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions